SIMALTO is designed to reveal what stakeholders value most when they have to balance real-world demands alongside cost. Rather than rating each feature in isolation, respondents are asked to make choices, showing what they are prepared to prioritise and what they are willing to give up.

 We recently ran an internal knowledge-sharing session on endpoints, something we address every day in our post market survey work. We took a step back to define their critical role in protocol and survey design, and how these feed into medical device evaluations and regulations.

At Purdie Pascoe, the best partnerships are the ones that make a real difference to how we work day-to-day, and Metaforms is a strong example of that. It is an AI-assisted platform that supports survey programming, helping turn complex questionnaires into live surveys with less manual effort. One project type that used to take about a week of programming now takes two to three days. For our team, that creates more space to respond when clients need updates with a quick turnaround.

Changing stakeholder perceptions requires more than understanding sentiment – it requires a clear, credible positioning strategy built on real-world feedback. Through a three-phase Delphi research programme, we helped our client refine, test and validate communications in a market where healthcare decision-makers were increasingly sceptical and under-informed.

As we reach the midpoint of 2026, a clear picture is emerging from the conversations we've been having across the MedTech industry. While the topics may seem different on the surface, many are converging around a broader shift in how organisations think about evidence, insight, and the journey from innovation to real-world adoption. Rather than a set of trends or predictions, these are recurring themes we're seeing in practice and believe will continue to shape decision-making across the industry.

DeviceTalks Boston 2026 brought together MedTech leaders, innovators, and investors to discuss the realities shaping medical device and technology development today. Kristy Beede, Research Director, and Nicole Levin, Associate Director, attended the conference, where the conversations reflected a sector that is becoming more connected, more data-driven, and increasingly focused on scalable, real‑world impact.

Many MedTech companies are rethinking the house of brands model as portfolios become more complex through platforms, digital ecosystems, and long-term partnerships. A stronger masterbrand can help scale trust across the portfolio, simplify complexity, and support adoption of new technologies and services.

We are delighted to be attending DeviceTalks Boston from 27–28 May 2026. Kristy Beede, Research Director, and Nicole Levin, Associate Director, will be representing Purdie Pascoe at the event.

 Behind every great research project is a system quietly keeping thousands of data points accurate, scalable, and insight ready. In this article, our Programming & Analytics experts explore how automation and innovation are transforming large-scale market research, freeing researchers to focus on what matters most: delivering meaningful insight.

After attending the Society of American Gastrointestinal and Endoscopic Surgeons Conference up the road in sunny Tampa, FL, it was easy to see why this year’s theme, connect to purpose, was so fitting. Across lectures, panels, posters, and exhibits, a consistent narrative emerged: surgeons, KOLs, engineers, and medical device manufacturers are deeply aligned in a shared mission to improve patient outcomes and elevate provider experience.

After attending the American College of Cardiology (ACC) Conference 2026, Molly Hines and Supreet Kaur reflected on their key takeaways from the event. At ACC, much of the discussion was shaped by how artificial intelligence is increasingly being embedded into clinical practice, workflows, and healthcare systems.

In this webcast our specialists Sabera Hyderally, Head of US MedTech and Kristin Lovallo, Director, will share how this advanced methodology can uncover deeper insights, helping organizations prioritize product features, refine value propositions, and make more confident strategic decisions.

Behavioural economics has long highlighted the importance of context. Data without context will only get you so far. MedTech companies need to understand why clinicians behave the way they do, how decisions actually get made inside hospitals, what ‘risk’ really means to different stakeholders and where friction exists within workflows, perceptions and emotions.

We are delighted to be attending the ACC Annual Conference from March 28–30 in New Orleans, Louisiana. Senior Research Executives Molly Hines and Supreet Kaur will be representing Purdie Pascoe at the event.

We are delighted to be attending the SAGES Annual Conference from March 25–28 in Tampa, Florida. Kristin Lovallo, US Research Director, will be representing Purdie Pascoe at the event.

Find out how we used a staged qualitative approach to help our client understand the landscape of digital solutions in GI endotherapy with a focus on AI, data management (clinical and non-clinical), workflow, and supply management.

It already feels like we’re flying through 2026, and the next wave of major MedTech conferences is coming into view fast. Calendars are filling, budgets are being committed, and plans are taking shape. The question is no longer whether to attend, but whether your conference research strategy is truly ready?

Real-World Evidence (RWE) is playing an increasingly important role in global MedTech regulatory decision-making, supporting evidence generation across the product lifecycle, from pre-market submissions to post-market surveillance. Watch this webcast which features industry experts to understand how MedTech manufacturers can build effective, compliant RWE strategies.

Our primary market research team combines deep expertise with a full range of qualitative and quantitative techniques, including the latest digital approaches with a wealth of experience across medical devices, digital healthcare, drug delivery, precision medicine and diagnostics.

Innovation sits right at the intersection of data, technology, and research. Our Innovation team’s goal is simple: make complex studies easier to run, insights easier to find, and decisions easier to make, for both our research colleagues and our clients.